Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Teleios Health vs Zera Health

Teleios Health
Graded #327

Lower grade

vs+14.599999999999994
Zera Health
Graded #61

Higher grade

The verdict

Zera Health takes it — 74.8/100 to 60.2/100.

Zera Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Zera Health is a telehealth platform for compounded GLP-1 weight loss — semaglutide from $149/mo, tirzepatide from $199/mo, plus oral and low-dose microdose options — prescribed by licensed physicians in…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleios Health +4
84
80
Dose & formulationZera Health +11
64
75
Clinical oversightZera Health +33
49
82
Labs & monitoringZera Health +5
48
53
FulfillmentZera Health +50
42
92
Contract termsEven
55
55
Teleios Health · left barZera Health · right bar

The numbers

MetricTeleios HealthZera Health
WeighScore60.2/10074.8/100
GradeCC
Scorecard rank#327#61
Semaglutide$99/mo (starting dose, compounded)$149/mo (compounded)
Tirzepatide$139/mo (starting dose, compounded)$199/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Teleios Health

Graded #327 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Zera Health

Graded #61 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo, plus a $129/mo microdose option
  • Flat pricing — the same monthly cost at every dose as you titrate up
  • All-inclusive: medication, unlimited 24/7 provider messaging, and free shipping bundled in
  • Names its compounding pharmacy — Strive Pharmacy (licensed 503A)
  • Available in all 50 states with same-day approvals

Where it loses points

  • Operates as a technology platform, not the medical provider itself
  • Compounded GLP-1s are not FDA-approved (the site discloses this honestly)
  • Aggressive marketing results claims (e.g. '18% average', '93% kept it off') with 'results not typical' disclaimers
  • Legal entity name not published (footer shows only 'Zera Health')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard